These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2198124)

  • 21. [Use of intravenous immunoglobulins in pediatrics].
    Duse M; Plebani A; Crispino P; Ugazio AG
    Pediatr Med Chir; 1991; 13(2):117-25. PubMed ID: 1896376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases].
    Klein M; Kaminsky P; Duc M
    Therapie; 1993; 48(2):97-103. PubMed ID: 8351694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
    Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
    Transplantation; 1995 Dec; 60(11):1225-30. PubMed ID: 8525515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cytomegalovirus specific IgG antibody following intravenous immunoglobulin in bone marrow transplant patients.
    Rand KH; Houck H; Ganju A; Babington RG; Elfenbein GJ
    Bone Marrow Transplant; 1989 Nov; 4(6):679-83. PubMed ID: 2555005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical use of intravenous immunoglobulin IgG].
    Permin H; Herlin T; Koch HG; Pedersen FK
    Ugeskr Laeger; 1992 Nov; 154(48):3411-6. PubMed ID: 1334293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg.
    Masson PL
    J Autoimmun; 1993 Dec; 6(6):683-9. PubMed ID: 8155250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates.
    Christensen RD; Hardman T; Thornton J; Hill HR
    J Perinatol; 1989 Jun; 9(2):126-30. PubMed ID: 2738720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoglobulins--merely expensive or also useful?].
    Paar WD
    Ther Umsch; 1995 Oct; 52(10):639-44. PubMed ID: 7482374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The viral safety of intravenous immune globulin.
    Yap PL
    Clin Exp Immunol; 1996 May; 104 Suppl 1():35-42. PubMed ID: 8625542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical uses of intravenous immune globulin: immunoglobulin replacement therapy and treatment of autoimmune cytopenias.
    Sorensen RU; Kallick MD
    J Clin Apher; 1988; 4(2-3):97-103. PubMed ID: 3397376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should therapeutic immunoglobulin be considered a generic product? An evidence-based approach.
    Misbah SA
    J Allergy Clin Immunol Pract; 2013; 1(6):567-72. PubMed ID: 24565702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy with immunoglobulins].
    Müller E; Zabel P
    Immun Infekt; 1990 Oct; 18(5):162-3. PubMed ID: 2265862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose.
    Berger M
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):532-8. PubMed ID: 21971330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of intravenous gamma globulin in autoimmune-mediated pediatric blood dyscrasias.
    Kurtzberg J; Friedman HS; Chaffee S; Falletta JM; Kinney TR; Kurlander R; Matthews TJ; Schwartz RS
    Am J Med; 1987 Oct; 83(4A):4-9. PubMed ID: 3118707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemolysis after intravenous immune globulin therapy: relation to IgG subclasses of red cell antibody.
    Okubo S; Ishida T; Yasunaga K
    Transfusion; 1990 Jun; 30(5):436-8. PubMed ID: 2360236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases.
    Ballow M
    J Allergy Clin Immunol; 1997 Aug; 100(2):151-7. PubMed ID: 9275133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in the half-life and clearance of IgG during therapy with intravenous gamma-globulin in 16 patients with severe primary humoral immunodeficiency.
    Schiff RI; Rudd C
    J Clin Immunol; 1986 May; 6(3):256-64. PubMed ID: 2424931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.